Division of Signal Transduction Therapy awarded the Queen's Anniversary Prize for Higher Education


All the Programme Leaders in the MRC Unit and four other Research Groups in the School of Life Sciences at the University of Dundee are involved in one of the largest research collaborations ever undertaken between the pharmaceutical industry and an academic institution in the UK, termed the Division of Signal Transduction Therapy (DSTT). Initiated in 1998 it has helped to launch over 100 new drug discovery programmes and is widely regarded as a model for how academic-industrial collaborations should work. The current participating companies are AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck & Co, Merck KGaA and Pfizer.

The achievement was recognised by a dinner at the Guildhall London on the evening of 15 February and on 16th February at Buckingham Palace the Queen and Duke of Edinburgh presented the University of Dundee with a Queen's Anniversary Prize for Higher Education. After the official ceremony the Queen and the Duke had informal discussions with other members of the DSTT who included Peter Downes, co-Director of the DSTT, Sir James Black, Chancellor of the University of Dundee, Hilary Mclauchlan and James Hastie, the Manager and Deputy Manager of the DSTT, Jennifer Bain, Head of the Kinase Profiling Service as well as Iva Klevernic and Sarah Ross who are graduate students working with Philip and Peter respectively.